These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

991 related items for PubMed ID: 18036082

  • 21. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia.
    Van der Heijden KB, Smits MG, Van Someren EJ, Ridderinkhof KR, Gunning WB.
    J Am Acad Child Adolesc Psychiatry; 2007 Feb; 46(2):233-41. PubMed ID: 17242627
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG, Ford I, Crawford G, McConnachie A, Nir T, Laudon M, Zisapel N.
    BMC Med; 2010 Aug 16; 8():51. PubMed ID: 20712869
    [Abstract] [Full Text] [Related]

  • 24. Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam.
    Uchimura N, Nakajima T, Hayash K, Nose I, Hashizume Y, Ohyama T, Habukawa M, Kotorii N, Kuwahara H, Maeda H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan 16; 30(1):22-9. PubMed ID: 16048734
    [Abstract] [Full Text] [Related]

  • 25. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
    Erman M, Seiden D, Zammit G, Sainati S, Zhang J.
    Sleep Med; 2006 Jan 16; 7(1):17-24. PubMed ID: 16309958
    [Abstract] [Full Text] [Related]

  • 26. Melatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years.
    Lyseng-Williamson KA.
    Drugs Aging; 2012 Nov 16; 29(11):911-23. PubMed ID: 23044640
    [Abstract] [Full Text] [Related]

  • 27. [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin®) in insomnia].
    Quera-Salva MA, Claustrat B.
    Encephale; 2018 Dec 16; 44(6):548-557. PubMed ID: 30107892
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial.
    Smits MG, van Stel HF, van der Heijden K, Meijer AM, Coenen AM, Kerkhof GA.
    J Am Acad Child Adolesc Psychiatry; 2003 Nov 16; 42(11):1286-93. PubMed ID: 14566165
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and tolerability of indiplon in older adults with primary insomnia.
    Walsh JK, Moscovitch A, Burke J, Farber R, Roth T.
    Sleep Med; 2007 Nov 16; 8(7-8):753-9. PubMed ID: 17825616
    [Abstract] [Full Text] [Related]

  • 31. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement.
    Hughes RJ, Sack RL, Lewy AJ.
    Sleep; 1998 Nov 16; 21(1):52-68. PubMed ID: 9485533
    [Abstract] [Full Text] [Related]

  • 32. The effects of ramelteon in a first-night model of transient insomnia.
    Zammit G, Schwartz H, Roth T, Wang-Weigand S, Sainati S, Zhang J.
    Sleep Med; 2009 Jan 16; 10(1):55-9. PubMed ID: 18691937
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Polysomnographic study of intermittent zolpidem treatment in primary sleep maintenance insomnia.
    Parrino L, Smerieri A, Giglia F, Milioli G, De Paolis F, Terzano MG.
    Clin Neuropharmacol; 2008 Jan 16; 31(1):40-50. PubMed ID: 18303490
    [Abstract] [Full Text] [Related]

  • 35. Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial.
    Cortesi F, Giannotti F, Sebastiani T, Panunzi S, Valente D.
    J Sleep Res; 2012 Dec 16; 21(6):700-9. PubMed ID: 22616853
    [Abstract] [Full Text] [Related]

  • 36. Validation of the sleep impact scale in patients with major depressive disorder and insomnia.
    Lasch K, Joish VN, Zhu Y, Rosa K, Qiu C, Crawford B.
    Curr Med Res Opin; 2009 Jul 16; 25(7):1699-710. PubMed ID: 19505198
    [Abstract] [Full Text] [Related]

  • 37. A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood.
    Serfaty MA, Osborne D, Buszewicz MJ, Blizard R, Raven PW.
    Int Clin Psychopharmacol; 2010 May 16; 25(3):132-42. PubMed ID: 20195158
    [Abstract] [Full Text] [Related]

  • 38. Tiagabine enhances slow wave sleep and sleep maintenance in primary insomnia.
    Walsh JK, Zammit G, Schweitzer PK, Ondrasik J, Roth T.
    Sleep Med; 2006 Mar 16; 7(2):155-61. PubMed ID: 16260179
    [Abstract] [Full Text] [Related]

  • 39. Melatonin treatment effects on adolescent students' sleep timing and sleepiness in a placebo-controlled crossover study.
    Eckerberg B, Lowden A, Nagai R, Akerstedt T.
    Chronobiol Int; 2012 Nov 16; 29(9):1239-48. PubMed ID: 23005039
    [Abstract] [Full Text] [Related]

  • 40. Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients--a double-blind and randomized study.
    Gann H, Feige B, Cloot O, Van Wasen H, Zinzgraf D, Hohagen F, Riemann D.
    Pharmacopsychiatry; 2004 Sep 16; 37(5):228-35. PubMed ID: 15359376
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.